Frontiers in Immunology Publishes New Study Data from IncellDx Supporting a Model for Understanding Long COVID’s Cause

SAN CARLOS, Calif.--(BUSINESS WIRE)--IncellDx, a precision medicine company, today announced the journal Frontiers in Immunology has published a study detailing a framework for understanding the potential mechanism of, and potential treatment for, Post-Acute Sequelae of COVID-19 (PASC), also known as long COVID or long haul COVID. “Recent analysis confirms long...

Click to view original post